Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial infarction associated with phenylpropanolamine.

R Oosterbaan1, M J Burns

  • 1Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

The Journal of Emergency Medicine
|January 25, 2000
PubMed
Summary

Phenylpropanolamine, a common nasal decongestant, can cause myocardial infarction (heart attack) even in young, healthy individuals. Overuse of this sympathomimetic agent may lead to serious cardiovascular events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of crosstalk in multielectrode arrays with local shielding.

Frontiers in nanotechnology·2024
Same author

An extended core nanocoax pillar architecture for enhanced molecular detection.

Biosensors & bioelectronics·2019
Same author

SABRE hyperpolarisation of vitamin B3 as a function of pH.

Chemical science·2017
Same author

Hot electron plasmon-protected solar cell.

Optics express·2015
Same author

Nanoscope based on nanowaveguides.

Optics express·2014
Same author

The suspected scaphoid injury: resource implications in the absence of magnetic resonance imaging.

Scottish medical journal·2013

Area of Science:

  • Pharmacology
  • Cardiology
  • Toxicology

Background:

  • Phenylpropanolamine is a widely accessible sympathomimetic amine.
  • It is a common ingredient in over-the-counter and prescription nasal decongestants.
  • The drug's mechanism involves alpha-adrenergic agonism, leading to vasoconstriction.

Observation:

  • A case study of a young woman without prior cardiac conditions is presented.
  • The patient experienced a myocardial infarction (heart attack).
  • This event occurred subsequent to unintentional overuse of a phenylpropanolamine-containing nasal decongestant.

Findings:

  • The case highlights a potential link between phenylpropanolamine overuse and myocardial infarction.
  • Pathophysiological mechanisms of drug-induced myocardial injury are discussed.

Related Experiment Videos

  • Serious adverse cardiovascular events, though uncommon, are possible with this agent.

    • Implications:

    • Healthcare providers should be aware of the cardiovascular risks associated with phenylpropanolamine.
    • Patient counseling regarding safe usage of decongestants is crucial.
    • This case underscores the potential for serious harm from widely available medications in susceptible individuals.